Literature DB >> 27870003

Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.

L Speigl1, N Janssen1, B Weide2, G Pawelec1,3, C Shipp1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27870003     DOI: 10.1111/bjd.15194

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Reporters of Cancer Stem Cells as a Tool for Drug Discovery.

Authors:  Amrutha Mohan; Reshma Raj R; Gayathri Mohan; Padmaja K P; Tessy Thomas Maliekal
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

2.  Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.

Authors:  Monica Marzagalli; Roberta Manuela Moretti; Elio Messi; Marina Montagnani Marelli; Fabrizio Fontana; Alessia Anastasia; Maria Rosa Bani; Giangiacomo Beretta; Patrizia Limonta
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 3.  Bladder cancer stem cells: clonal origin and therapeutic perspectives.

Authors:  Yi Li; Kaisu Lin; Zhao Yang; Ning Han; Xiaofang Quan; Xiangyang Guo; Chong Li
Journal:  Oncotarget       Date:  2017-07-08

4.  Resistance to drugs and cell death in cancer stem cells (CSCs).

Authors:  Ahmad R Safa
Journal:  J Transl Sci       Date:  2019-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.